Andrew Parker, PhD, executive drug development consultant, Quotient Sciences, explains how AI is integrated into pharmaceutical development.
News|Articles|August 1, 2002
- Pharmaceutical Technology-08-01-2002
- Volume 2002 Supplement
- Issue 1
Survey Reflects Growing Maturity of CMC Outsourcing
Author(s)Jim Miller
The results of this 2002 survey of contract services decision makers reviews and forecasts the state of the outsourcing industry.
Advertisement
Articles in this issue
about 24 years ago
Facilitating Client Audits:The Contract Laboratory Perspectiveabout 24 years ago
Contract Agreements and Methods of Managementabout 24 years ago
Keys to Managing Growth of Your Quality Organizationabout 24 years ago
Outsourcing Outlookabout 24 years ago
Are Project Management Services Right for You?about 24 years ago
Setting the Stage for Clinical Trial SuccessAdvertisement
Related to this article
2026 approvals, clinical data, and licensing deals are advancing subcutaneous biologics, reducing patient burden, and reshaping biopharma drug strategy.
Shilpa Pharma Lifesciences Limited will launch a new small-molecule CDMO at CPHI Milan in October.
This article explains the 4 shifts enabling faster, lower-risk, commercially successful biologics technology transfer.
Advertisement
Advertisement